These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 30310069)

  • 1. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
    Collet R; Caballero-Ávila M; Querol L
    Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of immune-mediated inflammatory neuropathies.
    Hadden RD; Hughes RA
    Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, epidemiology and treatment of inflammatory neuropathies.
    Baig F; Knopp M; Rajabally YA
    Br J Hosp Med (Lond); 2012 Jul; 73(7):380-5. PubMed ID: 22875431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Lindenbaum Y; Kissel JT; Mendell JR
    Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fisher syndrome and Bickerstaff brainstem encephalitis].
    Kuwabara S
    Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute and chronic inflammatory neuropathies--therapy].
    Köller H; Kieseier BC; Jander S; Hartung HP
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1405-7. PubMed ID: 12813675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.